TP53 and cancer: One previous study showed that the pro-neurotrophin-NGFR signaling can induce neuron death through the JNK-p53 pathway (Aloyz et al., 1998), but little is known about if this is also true in cancer or if NGFR can activate p53 independent of its ligands.